New York Society
of Interventional Pain Physicians
NYSIPP APC’s goals:
- To create an unbiased platform that improves access to evidence-based therapies in NY state through advocacy and policy.
- To create a repository of documents readily available for NYSIPP members for denial management.
Hemant Kalia, MD, Rochester
Chairman
Edward Rubin, MD, NYC
Board Member
Robert Tiso, MD, Syracuse
Board Member
Sam Nia, MD,
NYC
Board Member
Eugene Wang, MD, NYC
Board Member
Position Statements:
- NYSIPP Position Statement – Vertiflex – 2022
- NYSIPP Position Statement – mild® – 2024
- NYSIPP Position Statement – PNS – 2024
- NYSIPP Position Statement – PVA – 2024
Sample Letters:
Minutes of Meetings
AETNA – LCD Coverage
Cigna – Basivertebral Nerve Ablation
- Cigna BVNA Policy Points of Discussion Minutes 09-13-2023
- Cigna Medical Coverage Policy – Minimally Invasive Spine Surgery Procedures and Trigger Point Injections
- NASS Coverage Recommendations – Basivertebral Nerve Ablation
- NYSIPP Cigna BVN Letter
- SIS Letter
Fidelis/Centene – Epidural Blocks
Medicare/NGS – LCD clarification
NGS – Curonix PNS
NYSIPP Advocacy and Policy Consortium
P2P (Provider-to-Payor) Program
The goal of this program is to foster relationships with regional payors to address their specific local coverage determinant policies to cover evidence-based, FDA-approved therapies for interventional pain management.
Please provide further information about the therapy/policy you want APC to review by clicking the button below: